跳至主要内容
临床试验/NCT06373796
NCT06373796已完成不适用

Comparison of the Ultrasound Index Fat Fraction (FAT PLUS) With the MRI-PDFF Score for Quantification of Hepatic Steatosis.

SuperSonic Imagine1 个研究点 分布在 1 个国家目标入组 88 人开始时间: 2024年6月6日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
88
试验地点
1
主要终点
FAT PLUS

研究概览

简要总结

The objective is to compare the ultrasound index fat fraction (FAT PLUS), derived from several ultrasound biomarkers, with the gold-standard imaging exam for liver fat content evaluation (MRI-PDFF) in patients to quantify the hepatic steatosis.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 100 Years(Adult, Older Adult)
性别
All
接受健康志愿者
是

入选标准

  • •Subject is ≥ 18 years old.
  • •Subject is able to understand and sign the Informed Consent Form.
  • •Subject is able to stand and walk independently.
  • •Subject must have at least one or more routine ultrasound imaging procedures of the abdomen, at one of the participating study sites.
  • •Subject must have at least one routine liver MRI with PDFF score performed within 30 days before or after the ultrasound examination
  • •Subject is affiliated to National Social Insurance or a Health Insurance Regimen

排除标准

  • •Subject is unable or unwilling to adhere to Study procedures
  • •Subject is unable to understand the Informed Consent
  • •Subject is unable to express its consent
  • •Subject is under legal protection
  • •Subject is deprived of liberty by judicial or administrative decision
  • •Subject undergoes psychiatric treatment under constraint
  • •Subject is pregnant or breastfeeding
  • •Subject has latex allergy
  • •Subject has an open wound, cut, and/or a rash which would preclude an ultrasound imaging procedure

研究组 & 干预措施

FAT PLUS

Experimental

干预措施: Echographic scan (Device)

结局指标

主要结局

FAT PLUS

时间窗: 3 months

The objective is to compare the ultrasound index fat fraction (FAT PLUS), derived from several ultrasound biomarkers, with the gold-standard imaging exam for liver fat content evaluation (MRI-PDFF) in patients to quantify the hepatic steatosis.

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验